IV Low-Level Laser Treatment

Intravenous laser therapy to energise blood cells and reduce inflammation

Intravenous laser therapy (ILIB or UVBI) delivers specific wavelengths of low-level laser light directly into the bloodstream through a thin fibre-optic probe, stimulating red blood cell function, enhancing oxygen carrying capacity and exerting powerful anti-inflammatory effects at a systemic level.

Available in red, green, blue and UV wavelengths, each targeting different cellular and systemic effects, this non-pharmacological therapy is gaining recognition for chronic fatigue, autoimmune support and metabolic health.

Key Benefits

Directly stimulates red blood cell energy and oxygen delivery
Powerful systemic anti-inflammatory and immune-modulating effects
Supports metabolic function and cellular regeneration
Non-pharmacological with no drug interactions

Is This Treatment Right For You?

Patients with chronic fatigue, fibromyalgia or long-COVID effects
Those seeking anti-inflammatory support without medication
Patients with metabolic conditions wanting adjunct therapy

What to Expect

Assessment

Health history and treatment goals reviewed.

Probe Insertion

Thin fibre-optic probe placed into a peripheral vein.

Laser Treatment

Low-level laser delivered into the bloodstream over 20–30 minutes.

Programme

Series of sessions planned based on condition and goals.

Recovery & Aftercare

No downtime — the session is painless and non-invasive beyond the IV insertion.

Frequently Asked Questions

Is ILIB laser therapy painful?

No — beyond the minor sensation of IV insertion, the treatment is entirely painless.

What does the different wavelength colours do?

Red supports mitochondrial energy; green benefits metabolic and liver function; blue has antimicrobial and immune effects; UV stimulates immune response — your provider selects the appropriate wavelength.